Home Mailto
   Search
Login

   Minimize

Presentations 2010

XVIII International AIDS Conference Vienna

Oral

Impact of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy. L Wittkop on behalf of the EuroCoord-CHAIN joint project team.

Poster

PLATO II: Triple class virologic failure (TCVF) in HIV-infected children. Karina Butler on behalf of the PLATO II Project Team of COHERE

Presentations 2009

EACS Conference 11-14 November 2009 Cologne

Oral

1 CD4 count, viral suppression, prophylaxis and the risk of primary pneumocystis pneumonia in the cart era - the Collaboration of Observational HIV Epidemiological Research Europe (COHERE). Amanda Mocroft, for the Opportunistic Infections Working Group.

2 Mortality rates of elderly HIV-infected adults treated with antiretroviral are closer to general population than in younger patients. Charlotte Lewden on behalf of COHERE.

Posters

1 Presence of drug resistance during the course of treatment in patients who developed virological failure to the three original classes of antiretroviral drug. Frank de Wolf on behalf of COHERE.

2 Viral load outcome after virologic failure of the three original antiretroviral drug classes in 2000-2007. Dominique Costagliola on behalf of COHERE.

3 HIV-related Hodgkin lymphoma in the era of HAART: incidence and survival in a European mulit-cohort study. Julia Bohlius on behalf of COHERE.

16th Conference on Retroviruses and Opportunistic Infections, Montreal, February 2009  

Posters

1 Risk of extensive triple class virologic failure of the three original antiretroviral drug classes among people followed from therapy initiation with NNRTI or ritonavir-boosted PI regimens. R Lodwick on behalf of the PLATO II project team of COHERE. 
Poster 159 KB

2 Impact of cART on Incidence and Prognosis of HIV-1-associated Non-Hodgkin-Lymphoma - European Multi-Cohort Study. J Bohlius, M Egger, on behalf of the COHERE study group. 
Poster 517 KB

 

Presentations 2007

14th Conference o­n Retroviruses and Opportunistic Infections, Los Angeles, February 2007

Poster

1 Response to combination antiretroviral therapy (cART): variation by age.
CA Sabin for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study

Poster 528 as pdf file 216 KB


Updated: 19 Jul 2010